Current Cancer Therapy Reviews


Yangchao Chen
School of Biomedical Sciences
Faculty of Medicine
The Chinese University of Hong Kong
(Hong Kong)

Personal Subscription
Become EABM
Become Reviewer

Meet our Editorial Board Member free to download

Volume:16   Issue: 1
Pp: 1-1
Hie-Won Hann
DOI: 10.2174/157339471601200206091005

Preface free to download

Volume:16   Issue: 1
Pp: 2-2
Yangchao Chen
DOI: 10.2174/157339471601200206091136

Targeted Nanomedicines: In the Right Route Towards Improved Therapies free to download

Volume:16   Issue: 1
Pp: 3-4
Guillermina Ferro-Flores
DOI: 10.2174/1573394715666181224144500

Recent Advances of Novel Therapeutic Agents from Botanicals for Prevention and Therapy of Breast Cancer: An Updated Review

Volume:16   Issue: 1
Pp: 5-18
Namrata Singh, Poonam Kushwaha*, Amresh Gupta and Om Prakash
DOI: 10.2174/1573394715666181129101502

Role of the Hsp90-Immunophilin Heterocomplex in Cancer Biology

Volume:16   Issue: 1
Pp: 19-28
Sonia A. De Leo, Nadia R. Zgajnar, Gisela I. Mazaira, Alejandra G. Erlejman and Mario D. Galigniana*
DOI: 10.2174/1573394715666190102120801

Exploring Promises of siRNA in Cancer Therapeutics

Volume:16   Issue: 1
Pp: 29-35
Mahima Kaushik*, Rddhima Raghunand and Shobhit Maheshwari
DOI: 10.2174/1573394715666190207130128

Key Signaling Pathways Engaged in Cancer Management: Current Update

Volume:16   Issue: 1
Pp: 36-48
Sanjiv Singh* and Rahul Shukla
DOI: 10.2174/1573394714666180904122412

Possible Biomarkers and Therapeutic Targets for the Management of Cervical Cancer

Volume:16   Issue: 1
Pp: 49-61
Sombeer Sharma, Aakash Deep*, Avtar C. Rana, Monu Yadav and Arun K. Sharma
DOI: 10.2174/1573394715666190126142508

Cancer Immunotherapy: An Effective Tool in Cancer Control and Treatment open access plus

Volume:16   Issue: 1
Pp: 62-69
Kawalpreet Kaur and Gopal L. Khatik*
DOI: 10.2174/1573394715666190913184853

Virtual Screening of Novel Hybrid Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Exploring Multiple Targeted Cancer Therapy by an In Silico Approach open access plus

Volume:16   Issue: 1
Pp: 70-77
Ashish P. Shah* and Chhagan N. Patel
DOI: 10.2174/1573394715666190618114748

Identifying the Optimal Fractionation Schedules for Improved Response Rates and Survival in Patients with Metastatic Melanoma Treated with Ipilimumab and Radiotherapy

Volume:16   Issue: 1
Pp: 78-85
Jason Liu, Cong Xu, Junjia Zhu, Jeffrey Sivik, Joseph J. Drabick and Heath B. Mackley*
DOI: 10.2174/2542584601666180326111906